Bladder cancer screening has the potential to improve survival in high-risk patients by detecting tumors early, resulting in better outcomes. While some urine-based bladder tumor markers have demonstrated an improvement in bladder cancer detection over cytology or hematuria testing, they need to be evaluated in the setting of screening. More research is required to assess the feasibility and cost-effectiveness of screening prior to widespread use.
|Original language||English (US)|
|Number of pages||8|
|State||Published - Oct 1 2007|
ASJC Scopus subject areas
- Advanced and Specialized Nursing